You just read:

VistaGen Therapeutics Expands European Patent Protection for AV-101 for Treatment of Depression and Dyskinesia associated with Levodopa Therapy for Parkinson's Disease

News provided by

VistaGen Therapeutics

Oct 28, 2019, 08:30 ET